Advertisement
Home »

Pooled Safety Analysis of Single-Agent Lurbinectedin in Patients With Advanced Solid Tumours.

Aug 28, 2023

REFERENCES & ADDITIONAL READING

PubMed

ABOUT THE EXPERTS

  • Alexandra Leary

    Gustave Roussy Cancer Campus, Villejuif, France.

    Ana Oaknin

    Vall d’Hebron Hospital Campus and Institute of Oncology (VHIO), IOB-Quirón, UVic-UCC, Barcelona, Spain.

    José Manuel Trigo

    Hospital Universitario Virgen de la Victoria, Málaga, Spain.

    Victor Moreno

    START Madrid – FJD, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.

    Jean-Pierre Delord

    Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France.

    Valentina Boni

    NEXT Madrid, Universitary Hospital QuironSalud Madrid, Madrid, Spain; START Madrid – HM CIOCC, Hospital Madrid Norte Sanchinarro, Madrid, Spain.

    Irene Braña

    Vall d’Hebron Hospital Campus and Institute of Oncology (VHIO), IOB-Quirón, UVic-UCC, Barcelona, Spain.

    Cristian Fernández

    PharmaMar, Colmenar Viejo, Madrid, Spain.

    Carmen Kahatt

    PharmaMar, Colmenar Viejo, Madrid, Spain.

    Antonio Nieto

    PharmaMar, Colmenar Viejo, Madrid, Spain.

    Martin Cullell-Young

    PharmaMar, Colmenar Viejo, Madrid, Spain.

    Ali Zeaiter

    PharmaMar, Colmenar Viejo, Madrid, Spain.

    Vivek Subbiah

    Sarah Cannon Research Institute, Nashville, Tennessee, USA. Electronic address: Vivek.Subbiah@scri.com.

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


EXPLORE MORE

Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement